Henrik Cordes

Sanofi R&D
Frankfurt Am Main, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025.

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025.

Journal: CPT: pharmacometrics & systems pharmacology

Published: December 07, 2025

Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time Profiles.

Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time Profiles.

Journal: CPT: pharmacometrics & systems pharmacology

Published: December 02, 2025

Talk2Biomodels: AI agent-based open-source LLM initiative for kinetic biological models.

Talk2Biomodels: AI agent-based open-source LLM initiative for kinetic biological models.

Journal: BMC bioinformatics

Published: July 08, 2025

Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference.

Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference.

Journal: CPT: pharmacometrics & systems pharmacology

Published: December 19, 2024

Gene expression databases for physiologically based pharmacokinetic modeling of humans and animal species.

Gene expression databases for physiologically based pharmacokinetic modeling of humans and animal species.

Journal: CPT: pharmacometrics & systems pharmacology

Published: July 25, 2022

A Model-Based Workflow to Benchmark the Clinical Cholestasis Risk of Drugs.

A Model-Based Workflow to Benchmark the Clinical Cholestasis Risk of Drugs.

Journal: Clinical pharmacology and therapeutics

Published: February 23, 2021

Network integration and modelling of dynamic drug responses at multi-omics levels.

Network integration and modelling of dynamic drug responses at multi-omics levels.

Journal: Communications biology

Published: February 17, 2020

A 3D Heterotypic Multicellular Tumor Spheroid Assay Platform to Discriminate Drug Effects on Stroma versus Cancer Cells.

A 3D Heterotypic Multicellular Tumor Spheroid Assay Platform to Discriminate Drug Effects on Stroma versus Cancer Cells.

Journal: SLAS discovery : advancing life sciences R & D

Published: October 30, 2019

A Physiology-Based Model of Human Bile Acid Metabolism for Predicting Bile Acid Tissue Levels After Drug Administration in Healthy Subjects and BRIC Type 2 Patients.

A Physiology-Based Model of Human Bile Acid Metabolism for Predicting Bile Acid Tissue Levels After Drug Administration in Healthy Subjects and BRIC Type 2 Patients.

Journal: Frontiers in physiology

Published: February 18, 2019

Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling.

Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling.

Journal: Toxicology letters

Published: January 16, 2018

Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situations.

Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situations.

Journal: NPJ systems biology and applications

Published: October 16, 2017

Integration of genome-scale metabolic networks into whole-body PBPK models shows phenotype-specific cases of drug-induced metabolic perturbation.

Integration of genome-scale metabolic networks into whole-body PBPK models shows phenotype-specific cases of drug-induced metabolic perturbation.

Journal: NPJ systems biology and applications

Published: September 26, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026